3-(2-(anthracen-9-ylmethylene)hydrazinyl)-6-methyl-5H-[1,2,4]triazino[5,6-b]indole

ID: ALA4548914

PubChem CID: 6418917

Max Phase: Preclinical

Molecular Formula: C25H18N6

Molecular Weight: 402.46

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cccc2c1[nH]c1nc(N/N=C\c3c4ccccc4cc4ccccc34)nnc12

Standard InChI:  InChI=1S/C25H18N6/c1-15-7-6-12-20-22(15)27-24-23(20)29-31-25(28-24)30-26-14-21-18-10-4-2-8-16(18)13-17-9-3-5-11-19(17)21/h2-14H,1H3,(H2,27,28,30,31)/b26-14-

Standard InChI Key:  BDUKBHXDUOFMQX-WGARJPEWSA-N

Molfile:  

 
     RDKit          2D

 31 36  0  0  0  0  0  0  0  0999 V2000
   16.5075  -20.9787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5064  -21.7982    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2144  -22.2072    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2126  -20.5698    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.9212  -20.9751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9260  -21.7937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6983  -20.7176    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.1834  -21.3770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7031  -22.0394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0367  -22.7846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8504  -22.8684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3294  -22.2011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9931  -21.4587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7997  -20.5702    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0921  -20.9790    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3843  -20.5706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3841  -19.7534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4700  -20.7950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3857  -18.1216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0941  -18.5309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0907  -19.3466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7944  -19.7556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5019  -19.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5013  -18.5311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7970  -18.1258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6791  -19.3499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6765  -18.5360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9715  -18.1331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2686  -18.5430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2752  -19.3599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9808  -19.7591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  9  1  0
  8  7  1  0
  7  5  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  1 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 13 18  1  0
 17 21  2  0
 20 19  2  0
 19 27  1  0
 26 17  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 26  2  0
M  END

Associated Targets(Human)

HCRTR2 Tclin Orexin receptor 2 (5902 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCRTR1 Tclin Orexin receptor 1 (5435 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 402.46Molecular Weight (Monoisotopic): 402.1593AlogP: 5.57#Rotatable Bonds: 3
Polar Surface Area: 78.85Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.58CX Basic pKa: 4.51CX LogP: 5.94CX LogD: 5.92
Aromatic Rings: 6Heavy Atoms: 31QED Weighted: 0.23Np Likeness Score: -1.15

References

1. Turku A, Borrel A, Leino TO, Karhu L, Kukkonen JP, Xhaard H..  (2016)  Pharmacophore Model To Discover OX1 and OX2 Orexin Receptor Ligands.,  59  (18): [PMID:27546834] [10.1021/acs.jmedchem.6b00333]

Source